Elena V. Misharina

No ORCID on file · 12 papers in corpus · active 2018-2025

Study types

  • article 12

Condition tags

  • endometriosis 11
  • infertility 4
  • chronic_pelvic_pain 3
  • dysmenorrhea 1
  • die_deep_infiltrating 1
article 2025
·doi:10.17816/jowd636594

Background: Type 1 diabetes mellitus and endometriosis significantly reduce the quality of patient’s life and hinder the implementation of reproductive plans. Studying the features of the clinical course of endometriosis in patients with ty…

article 2025
·doi:10.17816/jowd697539

BACKGROUND: Endometriosis affects 5–10% of women of reproductive age worldwide. Despite the high prevalence of the disease, its diagnosis is usually delayed for several years and misdiagnosis is common, leading to delay in effective pathoge…

article 2025
·doi:10.17816/jowd696208

BACKGROUND: Previous studies leave no doubt as to the involvement of kisspeptin and oxytocin in the pathogenesis of endometriosis. Oxytocin and kisspeptin levels in the peripheral blood of patients with endometriosis were shown to be higher…

article 2025
·doi:10.17816/jowd699308

BACKGROUND: Uterine fibroids are hormone-dependent tumors in which the local microenvironment and the fibroid pseudocapsule play an important role. The oxytocin receptor, encoded by the OTR gene, may contribute to the regulation of contract…

article 2025
·doi:10.17816/jowd690093

This review article examines the role of oxidative stress in the pathogenesis of endometriosis and associated infertility, and discusses new treatment strategies aimed at improving the quality of life of patients with this pathology and the…

article 2023
·doi:10.17816/jowd345406

BACKGROUND: The prevalence of external genital endometriosis is high, yet there is insufficient understanding of its etiology and pathogenesis. This coupled with the challenges posed by its diagnosis and treatment, and its co-occurrence wit…

article 2023
·doi:10.17816/jowd567975

BACKGROUND: According to international data, about 5-10% of women of reproductive age suffer from this disease, while in women with chronic pelvic pain or infertility the incidence ranges from 35% to 50%. At the same time, women of reproduc…

article 2023
·doi:10.17816/jowd346690

BACKGROUND:Type 1 diabetes mellitus and genital endometriosis have a negative impact on female reproductive system. There is an opinion that kisspeptin plays an important role in the pathogenesis of ovarian insufficiency in patients with di…

article 2022
·doi:10.17816/jowd89528

AIM: The aim of this study was to analyze the association between the SNP surviving, the p53 gene polymorphisms and the risk of developing genital endometriosis and type 1 diabetes mellitus. MATERIALS AND METHODS: The frequency of allelic …

article 2021
·doi:10.17816/jowd70796

AIM: The aim of this study was to analyze the association between the vitamin D receptor gene polymorphism and the risk of developing genital endometriosis and type 1 diabetes mellitus. MATERIALS AND METHODS: The frequency of allelic varian…

article 2020
·doi:10.26442/20795696.2020.6.200486

In the structure of gynecological diseases, genital endometriosis takes the third place, and its frequency tends to increase. Endometriosis occurs in 510% of women of reproductive age, in 3550% of patients with infertility and in 7080% of w…

article 2018
·doi:10.17816/jowd67550-55

This article presents a review of the current literature on the impact of such drugs as gonadotropin-releasing hormone agonists, aromatase inhibitors, and dienogest 2 mg, which are used for the treatment of external genital endometriosis, o…